NEURORELIEF
LIVE

Serial Number

98372534

Owner

HARRIS, AUSTIN

Attorney

Benjamin Michael Mot

First Use Date

Aug 1, 2019

Filing Date

Jan 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NEURORELIEF Trademark

Serial Number: 98372534 • Registration: 7628440

NEURORELIEF is a trademark filed by HARRIS, AUSTIN on January 23, 2024. The trademark is classified under Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HARRIS, AUSTIN (5 trademarks)

12496 NUGENT DRIVE
GRANADA HILLS, CA 91344

Entity Type: 01

Trademark Details

Filing Date

January 23, 2024

Registration Date

December 24, 2024

First Use Anywhere

August 1, 2019

First Use in Commerce

January 1, 2020

Goods & Services

Peer to peer coaching services in the field addiction recovery; personal coaching services in the field of holistic healing; Personal development services; Life coaching services in the field of personal development; Education services, namely, providing panel discussions in the field of personal development; Professional coaching services in the field of personal development; personal coaching services in the field of personal development, integrating traditional coaching techniques, mindfulness, and somatic practices, internal family systems (IFS), and heart-centered communication for holistic growth and intentional living; Life coaching services in the field of personal development, including the exploration and utilization of resistance, fostering self-observation practices, recognizing and transforming life patterns, cultivating body awareness, and guiding the process of disidentification for enhanced clarity and personal growth

Medical services, namely, providing ketamine infusions for mental health support, relief from chronic pain, and aiding in substance and alcohol abuse recovery; Health care services, namely, pain management services; Medical services, namely, ketamine IV infusion and functional medicine; medical services, namely, nicotinamide adenine dinucleotide (NAD+) infusions administered intravenously for holistic pain relief; Platelet-rich plasma injections into joints and soft tissue for chronic pain relief; Behavioral health services; Behavioral health services in the nature of outpatient ketamine treatment services; Medical clinical services; Mental health services; Physician services; Providing medical therapies in the nature of infusion therapy services and blood therapy services for the treatment of chronic pain; medical therapy services; Medical clinic services; Medical consultancy; Health counseling; professional mental health services; Rehabilitation for substance abuse patients; Cognitive therapy services; Wellness and health-related consulting services; Mental health therapy services; Psychotherapy; Cognitive-Behavioral Therapy (CBT); Therapeutic services, namely, intravenous hydration therapy, intravenous vitamin infusion therapy, intravenous antioxidant infusion therapy, intravenous electrolyte infusion therapy, intravenous amino acid infusion therapy, and intravenous hangover alleviation therapy; Medicinal infusions in the nature of intravenous vitamin therapy services; Medical micronutrient IV therapy for relief of stress, depression, anxiety, and enhancing overall wellness, including improvements in energy, inflammation reduction, assistance with hydration, and support for the immune system; healthcare services, namely, wellness programs; wellness center providing mental health information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Dec 24, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Dec 2, 2024 CNTA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 27, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2024 NWOS
NEW APPLICATION ENTERED
Jan 24, 2024 NWAP